It’s no secret that medical marijuana can aid in pain relief. The increasingly popular medicinal marijuana has been in the news for being helpful in many medical situations but is hard to come by. Marijuana or cannabis contains compounds that may relieve pain, nausea, and other symptoms. The components of marijuana that most studies focus on for pain relief are cannabidiol (CBD) and tetrahydrocannabinol (THC). CBD does not cause a high, although it does interact with pain receptors in the brain to exert pain-relieving and anti-inflammatory effects.
CBD Oil Relieves Pain
Just aswillow barkwas the inspiration for aspirin and the poppy led to the discovery of opium, plant compounds have a rich history in human pain relief.
Several studies have shown that CBD has a significant impact on inflammatory and chronic pain. In a2006 animal study, CDB (taken orally or via injection) was capable of reducing persistent pain when administered daily for seven days. Anotherstudyfound that CBD not only lessened the sensation of pain but also helped reduce “affective pain” – or how we react to the unpleasantness of pain.
CBD Oil Eases the Side Effects of Chemotherapy
Over the course of the last two decades, medical marijuana has become a much more accepted treatment for a whole host of conditions, including helping to prevent and ease the adverse effects of chemotherapy.
Although more studies are needed to assess how CBD alone might help prevent chemotherapy-induced nausea and vomiting, astudypublished in 2010 revealed that cannabis with THC and CBD in equal measure provided better protection than standard antiemetic therapies.
Otherresearchsuggests that CBD may be the active component in relief from cancer-related pain. Comparing the effects of treatments using either a combination of THC and CBD, THC extract alone, or placebo, researchers found that pain was significantly reduced with the THC and CBD therapy, while the patients given only THC extract responded similarly to the placebo group.
CBD Oil Can Help Treat Epilepsy
The U.S. Food and Drug Administrationapprovedthe use of a drug derived from marijuana for the first time, giving the go-ahead to treat two rare forms of epilepsy with the compound cannabidiol, also known as CBD, found in hemp and marijuana.
“Epidiolex’s effectiveness was studied in three randomized, double-blind, placebo-controlled clinical trials involving 516 patients with either Lennox-Gastaut syndrome or Dravet syndrome. Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo.”
To read more, visit FDA News Room